Adicet Bio
ACET
ACET
77 hedge funds and large institutions have $68.3M invested in Adicet Bio in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 29 increasing their positions, 25 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
43% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 14
96% less call options, than puts
Call options by funds: $4K | Put options by funds: $90K
Holders
77
Holding in Top 10
–
Calls
$4K
Puts
$90K
Top Buyers
| 1 | +$3.33M | |
| 2 | +$808K | |
| 3 | +$378K | |
| 4 |
Two Sigma Investments
New York
|
+$256K |
| 5 |
Two Sigma Advisers
New York
|
+$252K |
Top Sellers
| 1 | -$1.09M | |
| 2 | -$662K | |
| 3 | -$457K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$367K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$229K |